Challenges and opportunities for further research involving the cannabis-to-opioid use transition
Bahji A, Milloy MJ, Bach P, Sociás ME., Addiction. 2022
Methodology
Commentary
Publications
The North American opioid crisis: how effective are supervised consumption sites?
Kennedy MC, Karamouzian M, Marshall BDL., Lancet. 2022
Intersecting HIV and mpox epidemics: more questions than answers
Girometti N., Ogoina D., Tan D.H.S., Pozniak A., Klein M.B., Journal of the International AIDS Society, 2022
Living longer with HIV: gains for some but not for all
Marina B. Klein, The Lancet HIV, 2023
RE: Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada
Elefante J, Nolan S, Bach P, CMAJ, 2023
Vigilance needed with methamphetamine-associated psychosis
Elefante RJO, Nolan S, Bach PJ., CMAJ. 2023
Evidence base to support using prescribed psychostimulants to treat psychostimulant use disorder is limited
Bahji A, Danilewitz M, George TP, Dhaliwal A, Crockford DN., CMAJ. 2023
Commentary on Brothers et al.: The role of safer environment interventions in addressing injecting-related bacterial and fungal infections
Small W, O’Callaghan S., Addiction. 2023
Universal Access to Opioid Agonist Therapy in Residential Treatment Settings: The Time Is Now
Muir P, Nolan S, Can J Addict, 2023
Author Reply to Letter to the Editor in Response to “Fentanyl Concentration in Drug Checking Samples and Risk of Overdose Death in Vancouver, Canada”
Kennedy MC, Tobias S, Dong H, Buxton JA, Lysyshyn M, Tupper KW, Ti L., Am J Prev Med. 2024
Fatal Drug Overdose Risks of Health Care Workers in the United States
Wood E, Bach P., Ann Intern Med. 2024
Harm reduction as treatment for Black and Hispanic individuals: response to Scheidell et al
Reed G, Socias ME., Am J Drug Alcohol Abuse. 2024
Capacity, Rationality, and the Promotion of Autonomy: A Trauma-Informed Approach to Refusals of Care After Opioid Poisoning
Cattell C, Hyshka E, Leier B, Mack C., Am J Bioeth., 2024
Redesigning a Stopped Clinical Trial as an Emulated Trial Using Real-World Data to Explore the Effectiveness of Slow-Release Oral Morphine as a Treatment for Opioid Use Disorder
Anand R, Penta S, Cui Z, Fairbairn N, Socias ME., Subst Use Addctn J. 2025
Expanding supervised consumption services in rural Canada: Bridging gaps
Mirza, N., Mathias, H., Hyshka, E., Can J Public Health
Responding to drug-related harm among South Asian populations in Canada
Mirza, N., Singh, M. & Hyshka, E., Can J Public Health
Cannabis legalization: a call for the integration of main health and crime indicator domains towards comprehensive policy impact assessments
Fischer B, Robinson T, Jutras-Aswad D., J Public Health Policy. 2025
Commentary on Coelho et al.: Ecological momentary assessments may be key to the future of cannabis studies
Chester L, Hebert FO, Jutras-Aswad D., Addiction. 2025
Scapegoated communities, shared struggles: A call for solidarity with people who use drugs and queer and trans people
Kira London‑Nadeau, Christian Barborini, Rebecca Haines‑Saah, Misha Bazarov, Sean Bristowe, Misha Khorkhordina, Mélodie Lemay‑Gaulin, Catherine Gorka, Robert‑Paul Juster, Heath D’Alessio, Nicholas Chadi, International Journal of Drug Policy, 2025
